The Malaria in Pregnancy (MiP) Library, now available on WWARN, is the most comprehensive database of malaria in pregnancy available. The Library allows you to search published and unpublished literature free of charge.

An individual patient data meta-analysis of 2,017 patients from 19 studies has found a high risk of recurrence following treatment of P. vivax malaria with artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) unless they are co-administered with primaquine. The research, published in...

A new study suggests that there are important but neglected issues with falsified and substandard medicines used to treat diabetes and that “no country is immune”.

Join us for the next Tropical Medicine Webinar 'Mapping and Tracking Malaria' on Wednesday 9th October at 09:30 GMT.

WWARN’s Clinical Scientific Group have published research in BMC Medical Research methodology and Malaria Journal comparing different statistical approaches for deriving cumulative estimates of drug efficacy from clinical studies. Results indicate that the Cumulative Incidence Function (CIF) approac...

We hope you enjoyed this year’s 11th European Congress on Tropical Medicine and International Health, ECTMIH 2019, as much as we did.

We hope you enjoyed this year’s 11th European Congress on Tropical Medicine and International Health, ECTMIH 2019, as much as we did.

Are you going to this year’s 11th European Congress on Tropical Medicine and International Health (ECTMIH) 16-20 September at the ACC in Liverpool, or the NNN Conference 17-19 September?

Are you going to this year’s 11th European Congress on Tropical Medicine and International Health (ECTMIH) 16-20 September at the ACC in Liverpool, between 17-19 September?

The British Society of Parasitology’s (BSP) three-day Spring Meeting is one of the biggest events in the society’s calendar and takes place at the University of Edinburgh from 15–17 April 2020. A strong malaria theme will run through the next meeting and IDDO is delighted to announce it will be open...

IDDO has launched a new global Chagas scientific collaboration with the Drugs for Neglected Diseases initiative (DNDi). The new platform will collate and standardise data to accelerate better treatments for the 6–7 million people worldwide with Chagas disease.

An IDDO/WWARN study has found that primaquine is not associated with increased levels of anaemia following treatment of patients without G6PD deficiency for P. vivax malaria and should be used as part of a radical cure. In the largest study of its kind to date, researchers carried out a systematic r...

Teams from IDDO and WWARN are excited to once again be taking part in the European Congress on Tropical Medicine and International Health, ECTMIH.

Researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment for uncomplicated falciparum malaria. The study, which is the first to specifically address this, has be...

There’s still time to apply for a National Institute for Health Research, NIHR, Global Health Policy and Systems Research Development Award.

IDDO's WWARN hosted a successful workshop in West Africa aimed at improving researchers’ skills. The aim of the workshops was two-fold; to train researchers in best practice of designing, conducting, analysing and reporting antimalarial drug clinical trials, and also to build expertise within the...

New research published in Open Forum Infectious Diseases has found that a longer follow-up is required to assess antimalarial drug efficacy in pregnant women. This was found across all drugs assessed in low malaria transmission settings. The report’s authors have called for guidelines specifically f...

IDDO’s visceral leishmaniasis (VL) collaboration is working on two new projects looking at the treatment of VL.

WWARN’s extensive scientific work has informed changes in dosage and combinations of antimalarial drugs and has led to policy change.

Le paludisme reste un problème de santé mondiale, en dépit de nombreux efforts coordonnés pour l'éradiquer. Un des obstacles à l'éradication est l'adaptation rapide du parasite aux médicaments antipaludiques, entrainant une résistance à ces médicaments. Pour de nombreux antipaludiques, les mécanisme...